• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

西班牙肾脏病学会理事会关于更新西班牙透析单位预防和隔离 SARS-CoV-2 措施建议的立场文件。

Update of the prevention and isolation measure recommendations against SARS-COV-2 in dialysis units of Spain: A position paper of the Spanish Society of Nephrology Council.

机构信息

Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, Spain.

Servicio de Nefrología, Hospital Universitario La Princesa, Madrid, Spain.

出版信息

Nefrologia (Engl Ed). 2022 Nov-Dec;42(6):714-721. doi: 10.1016/j.nefroe.2023.03.001. Epub 2023 Mar 6.

DOI:10.1016/j.nefroe.2023.03.001
PMID:36906502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9986128/
Abstract

SARS-CoV-2 pandemic has changed across the last two years. The development and approval of SARS-CoV-2 vaccines and the emergence of new variants has opened up a new scenario. On this regard, Spanish Society of Nephrology (S.E.N.) Council considers that an update of the previous recommendations should be performed. In the present statement, and taking into account the current epidemiological situation, are included updated recommendations of protection and isolation for patients on dialysis programs.

摘要

SARS-CoV-2 大流行在过去两年中发生了变化。SARS-CoV-2 疫苗的开发和批准以及新变种的出现开辟了一个新局面。关于这一点，西班牙肾脏病学会 (S.E.N.) 理事会认为应该对以前的建议进行更新。在本声明中，并考虑到当前的流行病学情况，包括了针对透析计划患者的保护和隔离的更新建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dddb/9986128/7e2ed85d1abb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dddb/9986128/7e2ed85d1abb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dddb/9986128/7e2ed85d1abb/gr1_lrg.jpg

相似文献

1
Update of the prevention and isolation measure recommendations against SARS-COV-2 in dialysis units of Spain: A position paper of the Spanish Society of Nephrology Council.西班牙肾脏病学会理事会关于更新西班牙透析单位预防和隔离 SARS-CoV-2 措施建议的立场文件。
Nefrologia (Engl Ed). 2022 Nov-Dec;42(6):714-721. doi: 10.1016/j.nefroe.2023.03.001. Epub 2023 Mar 6.
2
[Update of the prevention and isolation measure recommendations against SARS-COV-2 in dialysis units of Spain: A position paper of the Spanish Society of Nephrology Council].[西班牙透析单位针对新型冠状病毒肺炎的预防与隔离措施建议更新：西班牙肾脏病学会理事会立场文件]
Nefrologia. 2022 Nov-Dec;42(6):714-721. doi: 10.1016/j.nefro.2022.10.001. Epub 2022 Oct 12.
3
Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines.西班牙肾脏病学会关于 SARS-CoV-2 疫苗的立场声明。
Nefrologia (Engl Ed). 2021 Jul-Aug;41(4):412-416. doi: 10.1016/j.nefroe.2021.09.001. Epub 2021 Sep 22.
4
Impact of the COVID-19 pandemic on Spanish Nephrology Services.新冠疫情对西班牙肾脏病服务的影响。
Nefrologia (Engl Ed). 2020 Nov-Dec;40(6):579-584. doi: 10.1016/j.nefro.2020.08.002. Epub 2020 Oct 6.
5
SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN).接受肾脏替代治疗患者的新型冠状病毒2型感染。西班牙肾脏病学会（SEN）COVID-19登记报告。
Nefrologia (Engl Ed). 2020 May-Jun;40(3):272-278. doi: 10.1016/j.nefro.2020.04.002. Epub 2020 Apr 16.
6
Management of Hemodialysis Patients with Suspected or Confirmed COVID-19 Infection: Perspective from the Spanish Nephrology.疑似或确诊 COVID-19 感染血液透析患者的管理：来自西班牙肾脏病学会的观点。
Kidney360. 2020 Sep 11;1(11):1254-1258. doi: 10.34067/KID.0002602020. eCollection 2020 Nov 25.
7
Going to war with COVID-19: Strategies for SARS-CoV-2 management in the Padua Nephrology and Dialysis Unit's hemodialysis facility.与新冠病毒作战：帕多瓦肾脏病与透析科血液透析设施中新冠病毒管理策略
Clin Nephrol. 2021 Mar;95(3):151-156. doi: 10.5414/CN110330.
8
[Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines].[西班牙肾脏病学会关于SARS-CoV-2疫苗的立场声明]
Nefrologia. 2021 Jul-Aug;41(4):412-416. doi: 10.1016/j.nefro.2020.12.002. Epub 2021 Jan 1.
9
[Update 2021: COVID-19 from the perspective of nephrology].[2021年更新：肾脏病学视角下的新型冠状病毒肺炎]
Dtsch Med Wochenschr. 2021 Jul;146(13-14):915-917. doi: 10.1055/a-1449-5068. Epub 2021 Jul 13.
10
Good Practice Recommendations from the Brazilian Society of Nephrology to Dialysis Units Concerning the Pandemic of the New Coronavirus (Covid-19).巴西肾脏病学会针对新型冠状病毒（Covid-19）大流行向透析单位提出的良好实践建议。
J Bras Nefrol. 2020 Aug 26;42(2 suppl 1):15-17. doi: 10.1590/2175-8239-JBN-2020-S105.

引用本文的文献

1
Impact of the COVID-19 Pandemic in Spain in the Successive Pandemic Waves on Hemodialysis Patients and Healthcare Personnel.新冠疫情在西班牙连续几波疫情期间对血液透析患者及医护人员的影响
J Clin Med. 2023 Jun 28;12(13):4337. doi: 10.3390/jcm12134337.

本文引用的文献

1
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry.疫苗时代接受肾脏替代治疗的COVID-19患者的病情不断演变，但死亡率持续居高不下：西班牙COVID-19肾脏替代治疗登记处
Clin Kidney J. 2022 Jun 3;15(9):1685-1697. doi: 10.1093/ckj/sfac135. eCollection 2022 Sep.
2
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis.严重急性呼吸综合征冠状病毒2型奥密克戎变异株阳性个体中无症状感染的百分比：一项系统评价和荟萃分析
Vaccines (Basel). 2022 Jun 30;10(7):1049. doi: 10.3390/vaccines10071049.
3
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum.
慢性肾脏病范围内对第三剂严重急性呼吸综合征冠状病毒2疫苗的体液反应
Clin J Am Soc Nephrol. 2022 Jun;17(6):872-876. doi: 10.2215/CJN.01770222. Epub 2022 May 12.
4
SARS-CoV-2 Infection Evolution Among Nephrologists During the Pandemic: Clinical Features and Impact of Vaccination.大流行期间肾病学家中新型冠状病毒2感染的演变：临床特征及疫苗接种的影响
Kidney Int Rep. 2022 Jul;7(7):1686-1689. doi: 10.1016/j.ekir.2022.04.093. Epub 2022 May 5.
5
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.COVID-19 与透析：临床影响、免疫反应、预防和治疗。
Kidney Int. 2022 May;101(5):883-894. doi: 10.1016/j.kint.2022.01.022. Epub 2022 Feb 14.
6
Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.奥密克戎 SARS-CoV-2 新变体：全球流行情况以及生物学和临床特征。
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8012-8018. doi: 10.26355/eurrev_202112_27652.
7
Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.慢性肾脏病患者 COVID-19 疫苗的安全性和即刻体液免疫应答：SENCOVAC 研究。
Nephrol Dial Transplant. 2022 Sep 22;37(10):1868-1878. doi: 10.1093/ndt/gfab313.
8
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.mRNA 疫苗接种与 COVID-19 住院和疾病严重程度的关联。
JAMA. 2021 Nov 23;326(20):2043-2054. doi: 10.1001/jama.2021.19499.
9
Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines.西班牙肾脏病学会关于 SARS-CoV-2 疫苗的立场声明。
Nefrologia (Engl Ed). 2021 Jul-Aug;41(4):412-416. doi: 10.1016/j.nefroe.2021.09.001. Epub 2021 Sep 22.
10
Can the cycle threshold (Ct) value of RT-PCR test for SARS CoV2 predict infectivity among close contacts?实时逆转录聚合酶链反应（RT-PCR）检测新型冠状病毒（SARS-CoV-2）的循环阈值（Ct）值能否预测密切接触者的传染性？
J Infect Public Health. 2021 Sep;14(9):1201-1205. doi: 10.1016/j.jiph.2021.08.013. Epub 2021 Aug 13.